|
1
|
Li P, Zhu K, Mo Y, Deng X, Jiang X, Shi L,
Guo C, Zhang W, Zeng Z, Li G, et al: Research Progress of circRNAs
in Head and Neck Cancers. Front Oncol. 11:6162022021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mehanna H, Hardman JC, Shenson JA,
Abou-Foul AK, Topf MC, AlFalasi M, Chan JYK, Chaturvedi P, Chow
VLY, Dietz A, et al: Recommendations for head and neck surgical
oncology practice in a setting of acute severe resource constraint
during the COVID-19 pandemic: An international consensus. Lancet
Oncol. 21:e350–e359. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang C, Liao X, Ma Z, Liu S, Fang F and
Mai H: Overexpression of β-Adrenergic Receptors and the Suppressive
Effect of β(2)-Adrenergic Receptor Blockade in Oral Squamous Cell
Carcinoma. J Oral Maxillofac Surg. 78:1871.e1871–1871.e1823. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haldar R, Ricon-Becker I, Radin A, Gutman
M, Cole SW, Zmora O and Ben-Eliyahu S: Perioperative COX2 and
β-adrenergic blockade improves biomarkers of tumor metastasis,
immunity, and inflammation in colorectal cancer: A randomized
controlled trial. Cancer. 126:3991–4001. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chaudhary KR, Yan SX, Heilbroner SP,
Sonett JR, Stoopler MB, Shu C, Halmos B, Wang TJC, Hei TK and Cheng
SK: Effects of β-Adrenergic Antagonists on Chemoradiation Therapy
for Locally Advanced Non-Small Cell Lung Cancer. J Clin Med.
8:5752019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yap A, Lopez-Olivo MA, Dubowitz J, Pratt
G, Hiller J, Gottumukkala V, Sloan E, Riedel B and Schier R: Effect
of beta-blockers on cancer recurrence and survival: A meta-analysis
of epidemiological and perioperative studies. Br J Anaesth.
121:45–57. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Weberpals J, Jansen L, Carr PR,
Hoffmeister M and Brenner H: Beta blockers and cancer prognosis -
The role of immortal time bias: A systematic review and
meta-analysis. Cancer Treat Rev. 47:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wolter NE, Wolter JK, Enepekides DJ and
Irwin MS: Propranolol as a novel adjunctive treatment for head and
neck squamous cell carcinoma. J Otolaryngol Head Neck Surg.
41:334–344. 2012.PubMed/NCBI
|
|
9
|
Silverman DA, Martinez VK, Dougherty PM,
Myers JN, Calin GA and Amit M: Cancer-Associated Neurogenesis and
Nerve-Cancer Cross-talk. Cancer Res. 81:1431–1440. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang B, Wu C, Chen W, Qiu L, Li S, Wang
T, Xie H, Li Y, Li C and Li L: The stress hormone norepinephrine
promotes tumor progression through β2-adrenoreceptors in oral
cancer. Arch Oral Biol. 113:1047122020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shang ZJ, Liu K and Liang DF: Expression
of beta2-adrenergic receptor in oral squamous cell carcinoma. J
Oral Pathol Med. 38:371–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schallreuter KU, Lemke KR, Pittelkow MR,
Wood JM, Körner C and Malik R: Catecholamines in human keratinocyte
differentiation. J Invest Dermatol. 104:953–957. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang PY, Huang WY, Lin CL, Huang TC, Wu
YY, Chen JH and Kao CH: Propranolol Reduces Cancer Risk: A
Population-Based Cohort Study. Medicine (Baltimore). 94:e10972015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim SA, Moon H, Roh JL, Kim SB, Choi SH,
Nam SY and Kim SY: Postdiagnostic use of β-blockers and other
antihypertensive drugs and the risk of recurrence and mortality in
head and neck cancer patients: An observational study of 10,414
person-years of follow-up. Clin Transl Oncol. 19:826–833. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sugiura T, Inoue Y, Matsuki R, Ishii K,
Takahashi M, Abe M and Shirasuna K: VEGF-C and VEGF-D expression is
correlated with lymphatic vessel density and lymph node metastasis
in oral squamous cell carcinoma: Implications for use as a
prognostic marker. Int J Oncol. 34:673–680. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bernabé DG, Tamae AC, Biasoli ÉR and
Oliveira SH: Stress hormones increase cell proliferation and
regulates interleukin-6 secretion in human oral squamous cell
carcinoma cells. Brain Behav Immun. 25:574–583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bravo-Calderón DM, Oliveira DT, Marana AN,
Nonogaki S, Carvalho AL and Kowalski LP: Prognostic significance of
beta-2 adrenergic receptor in oral squamous cell carcinoma. Cancer
Biomark. 10.51–59. 2011-2012.
|
|
18
|
Vilardi BM, Bravo-Calderón DM, Bernabé DG,
Oliveira SH and Oliveira DT: VEGF-C expression in oral cancer by
neurotransmitter-induced activation of beta-adrenergic receptors.
Tumour Biol. 34:139–143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie H, Li C, He Y, Griffin R, Ye Q and Li
L: Chronic stress promotes oral cancer growth and angiogenesis with
increased circulating catecholamine and glucocorticoid levels in a
mouse model. Oral Oncol. 51:991–997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bravo-Calderón DM, Assao A, Garcia NG,
Coutinho-Camillo CM, Roffé M, Germano JN and Oliveira DT: Beta
adrenergic receptor activation inhibits oral cancer migration and
invasiveness. Arch Oral Biol. 118:1048652020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang EV, Sood AK, Chen M, Li Y, Eubank TD,
Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, et al:
Norepinephrine up-regulates the expression of vascular endothelial
growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in
nasopharyngeal carcinoma tumor cells. Cancer Res. 66:10357–10364.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Doescher J, Veit JA and Hoffmann TK: The
8th edition of the AJCC Cancer Staging Manual: Updates in
otorhinolaryngology, head and neck surgery. HNO. 65:956–961.
2017.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang B, Gao J, Zhang Q, Fu Y, Liu G, Shi
J, Li D, Wang F and Guo H: Diagnostic Value of 68Ga-PSMA PET/CT for
Detection of Phosphatase and Tensin Homolog Expression in Prostate
Cancer: A Pilot Study. J Nucl Med. 61:873–880. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bankhead P, Loughrey MB, Fernández JA,
Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ,
Coleman HG, et al: QuPath: Open source software for digital
pathology image analysis. Sci Rep. 7:168782017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo K, Ma Q, Wang L, Hu H, Li J, Zhang D
and Zhang M: Norepinephrine-induced invasion by pancreatic cancer
cells is inhibited by propranolol. Oncol Rep. 22:825–830.
2009.PubMed/NCBI
|
|
27
|
Yang EV, Kim SJ, Donovan EL, Chen M, Gross
AC, Webster Marketon JI, Barsky SH and Glaser R: Norepinephrine
upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor
cell lines: Implications for stress-related enhancement of tumor
progression. Brain Behav Immun. 23:267–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Motiejunaite J, Amar L and Vidal-Petiot E:
Adrenergic receptors and cardiovascular effects of catecholamines.
Ann Endocrinol (Paris). 82:193–197. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Patel PR, Hegde ML, Theruvathu J, Mitra
SA, Boldogh I and Sowers L: Norepinephrine Reduces Reactive Oxygen
Species (ROS) and DNA Damage in Ovarian Surface Epithelial Cells. J
Bioanal Biomed. 7:75–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bastos DB, Sarafim-Silva BAM, Sundefeld
MLMM, Ribeiro AA, Brandão JDP, Biasoli ÉR, Miyahara GI, Casarini DE
and Bernabé DG: Circulating catecholamines are associated with
biobehavioral factors and anxiety symptoms in head and neck cancer
patients. PLoS One. 13:e02025152018. View Article : Google Scholar : PubMed/NCBI
|
